Clinical Trial Update: Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on human umbilical-cord-derived mesenchymal stem cell therapy for paraquat-induced lung injury, currently in Phase 1/Phase 2 with an unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Paraquat Poisoning

Drugs mentioned

• Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy (mesenchymal stem cells (umbilical cord-derived))

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Paraquat Poisoning, Lung Injury | Phase 1, Phase 2 | Status: UNKNOWN